Pangenotypic Regimens and the Next Generation of HCV Treatment
AASLD LiverLearning®. Reau N. Nov 14, 2016; 154728
Topic: Treatment
Dr. Nancy Reau
Dr. Nancy Reau

AASLD Members enjoy free LiverLearning® Premium Access. Registrants of The Liver Meeting® receive LiverLearning® Premium Access for one year from the first day of the meeting.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions